웹GUANGZHOU, China--(BUSINESS WIRE)--Bio-Thera Solutions, a clinical-stage pharmaceutical company, today announced that patient dosing has begun in a Phase I … 웹Bio-Thera Solutions (Bio-Thera) is a clinical-stage biopharmaceutical company that carries out the research and development, production of innovative drugs and biosimilars. The company’s pipeline products include humanized monoclonal antibodies and peptide drugs such as BAT8001, BAT8003, BAT1306, BAT2094, and BAT4306F.
东方财富网投资者互动平台:构建投资者与上市公司之间便捷的 ...
웹2024-04-17 BAT4306F Approved for Phase I Clinical Trials in China; 2024-03-30 Bio-Thera Solutions Announces Two Poster Presentations at the 2024 AACR Annual Meeting; 2024-01-05 Bio-Thera Solutions to Present at the Biotech … 웹2024년 3월 10일 · 药乱了 多发性硬化症是中枢神经系统罕见疾病,发病反复无常,给患者和家属带来各方面沉重负担。 幸运的是,全球对该罕见病的药物研发热情高涨,已有14种药物 … arabian date site
$百奥泰(SH688177)$ 百奥泰管线初期药物梳理:肿瘤类。比较有潜 …
웹2024년 12월 7일 · Press release content from Business Wire. The AP news staff was not involved in its creation. 웹招股书显示,百奥泰的研发管线中,除了刚刚获批上市的bat1406,还有20个在研产品,其中4个产品(bat1706、bat8001、bat1806、bat2094)处于iii期临床研究阶段,1个产品(bat1306)属于ii期临床阶段,4个产品(bat8003、bat4306f、bat5906、bat2506)处于i期临床阶段,其他处于临床前研究阶段。 웹Condition. Non-Hodgkin's Lymphoma. A Phase I Clinical Trial of BAT4306F (for Injection) on Safety, Tolerability and Pharmacokinetics for Patients With CD20-positive, B-cell Non … baixar addons para kodi brazuca